Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PTC THERAPEUTICS, INC.PTCT · Entity 3803 | SVP, CHIEF ACCOUNTING OFFICER | June 17, 2026 | June 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PTC THERAPEUTICS, INC.
Report date June 17, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 70,199 |
Ending reported balance
After 2026-06-17 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-17 · Exercise / conversion · Acquired 19,686 · Balance 89,885 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2026. Row 2 · 2026-06-17 · Sale · Disposed 19,686 · Balance 70,199 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2026. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.69 · Expires 2034-02-14 | Direct | 15,314 |
Reported balance
After 2026-06-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-17 · Exercise / conversion · Disposed 19,686 · Balance 15,314 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2026. F2: This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2026.
F2: This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 2,500 | $18.01 | $45,025.00 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 7 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 355 | $60.00 | $21,300.00 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 6 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,562 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 355 | $18.01 | $6,393.55 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 5 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 688 | $60.00 | $41,280.00 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 4 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,562 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 688 | $30.86 | $21,231.68 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 3 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 1,567 | $60.20 | $94,333.40 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,562 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 1,567 | $30.86 | $48,357.62 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,129 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| October 06, 2020 Filed Oct 8, 2020 00:59 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $18.01 Strike: $18.01 | $45,025.00 |
DisclosureSEC source: 0001179110-20-010347 · edgar.xml · derivative · entry 6 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,355 Underlying: Common Stock · 2,500 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. F4 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| October 06, 2020 Filed Oct 8, 2020 00:59 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 2,500 | $50.08 | $125,207.50 |
DisclosureSEC source: 0001179110-20-010347 · edgar.xml · nonDerivative · entry 4 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,562 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $50.00 to $50.36 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 06, 2020 Filed Oct 8, 2020 00:59 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 2,500 | $18.01 | $45,025.00 |
DisclosureSEC source: 0001179110-20-010347 · edgar.xml · nonDerivative · entry 3 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 00:59 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 787 | $11.23 Strike: $11.23 | $8,838.01 |
DisclosureSEC source: 0001179110-20-010347 · edgar.xml · derivative · entry 5 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 788 Underlying: Common Stock · 787 shares Expires 2027-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. F3 · derivative.exercise_date: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 00:59 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 787 | $48.68 | $38,311.16 |
DisclosureSEC source: 0001179110-20-010347 · edgar.xml · nonDerivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,562 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 00:59 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 787 | $11.23 | $8,838.01 |
DisclosureSEC source: 0001179110-20-010347 · edgar.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 20:04 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 2,500 | $18.01 Strike: $18.01 | $45,025.00 |
DisclosureSEC source: 0001070081-20-000116 · wf-form4_159423864174202.xml · derivative · entry 7 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,855 Underlying: Common Stock · 2,500 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 29, 2019. F6 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 20:04 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 788 | $11.23 Strike: $11.23 | $8,849.24 |
DisclosureSEC source: 0001070081-20-000116 · wf-form4_159423864174202.xml · derivative · entry 6 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 Underlying: Common Stock · 788 shares Expires 2027-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 29, 2019. F5 · derivative.exercise_date: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 20:04 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 500 | $54.40 | $27,202.00 |
DisclosureSEC source: 0001070081-20-000116 · wf-form4_159423864174202.xml · nonDerivative · entry 5 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,562 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 29, 2019. F4 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.25 to $54.62 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 20:04 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 2,000 | $53.81 | $107,614.00 |
DisclosureSEC source: 0001070081-20-000116 · wf-form4_159423864174202.xml · nonDerivative · entry 4 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,062 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 29, 2019. F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.14 to $54.13 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 20:04 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 2,500 | $18.01 | $45,025.00 |
DisclosureSEC source: 0001070081-20-000116 · wf-form4_159423864174202.xml · nonDerivative · entry 3 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 29, 2019. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 20:04 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 788 | $52.98 | $41,748.24 |
DisclosureSEC source: 0001070081-20-000116 · wf-form4_159423864174202.xml · nonDerivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,562 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 29, 2019. Read SEC document |
| July 06, 2020 Filed Jul 8, 2020 20:04 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 788 | $11.23 | $8,849.24 |
DisclosureSEC source: 0001070081-20-000116 · wf-form4_159423864174202.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 29, 2019. F2 · balance_after: Includes 258 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2020. Read SEC document |
| April 17, 2020 Filed Apr 21, 2020 20:15 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 2,145 | $18.01 Strike: $18.01 | $38,631.45 |
DisclosureSEC source: 0001070081-20-000084 · wf-form4_158750008397467.xml · derivative · entry 3 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,355 Underlying: Common Stock · 2,145 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. F2 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| April 17, 2020 Filed Apr 21, 2020 20:15 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 2,145 | $50.00 | $107,250.00 |
DisclosureSEC source: 0001070081-20-000084 · wf-form4_158750008397467.xml · nonDerivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,304 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. Read SEC document |
| April 17, 2020 Filed Apr 21, 2020 20:15 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 2,145 | $18.01 | $38,631.45 |
DisclosureSEC source: 0001070081-20-000084 · wf-form4_158750008397467.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 20:05 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 787 | $11.23 Strike: $11.23 | $8,838.01 |
DisclosureSEC source: 0001070081-20-000070 · wf-form4_158628989510799.xml · derivative · entry 3 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,363 Underlying: Common Stock · 787 shares Expires 2027-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. F2 · derivative.exercise_date: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 20:05 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 787 | $44.31 | $34,871.97 |
DisclosureSEC source: 0001070081-20-000070 · wf-form4_158628989510799.xml · nonDerivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,304 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 20:05 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 787 | $11.23 | $8,838.01 |
DisclosureSEC source: 0001070081-20-000070 · wf-form4_158628989510799.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 21:42 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right To Buy) · Derivative | 23,800 | $0.00 Strike: $51.16 | $0.00 |
DisclosureSEC source: 0001070081-20-000050 · wf-form4_158050692955706.xml · derivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,800 Underlying: Common Stock · 23,800 shares Expires 2030-01-28 F2 · derivative.exercise_date: This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 21:42 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 4,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001070081-20-000050 · wf-form4_158050692955706.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,304 F1 · shares: Restricted stock units granted on January 29, 2020 that vest in four equal installments over four years, commencing on January 29, 2021. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 23:07 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 7,500 | $18.01 Strike: $18.01 | $135,075.00 |
DisclosureSEC source: 0001070081-20-000013 · wf-form4_157852483759758.xml · derivative · entry 7 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 7,500 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. F5 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 23:07 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 6,250 | $13.10 Strike: $13.10 | $81,875.00 |
DisclosureSEC source: 0001070081-20-000013 · wf-form4_157852483759758.xml · derivative · entry 6 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,250 shares Expires 2027-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. F4 · derivative.exercise_date: Currently exercisable. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 23:07 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 7,500 | $50.03 | $375,232.50 |
DisclosureSEC source: 0001070081-20-000013 · wf-form4_157852483759758.xml · nonDerivative · entry 5 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,224 F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $50.00 to $50.09 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 23:07 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 7,500 | $18.01 | $135,075.00 |
DisclosureSEC source: 0001070081-20-000013 · wf-form4_157852483759758.xml · nonDerivative · entry 4 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 23:07 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 6,250 | $50.00 | $312,500.00 |
DisclosureSEC source: 0001070081-20-000013 · wf-form4_157852483759758.xml · nonDerivative · entry 3 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,224 F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 23:07 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 6,250 | $13.10 | $81,875.00 |
DisclosureSEC source: 0001070081-20-000013 · wf-form4_157852483759758.xml · nonDerivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 23:07 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 360 | $48.17 | $17,340.48 |
DisclosureSEC source: 0001070081-20-000013 · wf-form4_157852483759758.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,224 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 975 RSUs from a January 3, 2017 grant of 3,900 RSUs. Read SEC document |
| January 03, 2020 Filed Jan 6, 2020 21:52 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 788 | $11.23 Strike: $11.23 | $8,849.24 |
DisclosureSEC source: 0001070081-20-000003 · wf-form4_157834756203774.xml · derivative · entry 6 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,150 Underlying: Common Stock · 788 shares Expires 2027-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. F4 · derivative.exercise_date: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. Read SEC document |
| January 03, 2020 Filed Jan 6, 2020 21:52 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 788 | $47.42 | $37,366.96 |
DisclosureSEC source: 0001070081-20-000003 · wf-form4_157834756203774.xml · nonDerivative · entry 4 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,584 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. Read SEC document |
| January 03, 2020 Filed Jan 6, 2020 21:52 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 788 | $11.23 | $8,849.24 |
DisclosureSEC source: 0001070081-20-000003 · wf-form4_157834756203774.xml · nonDerivative · entry 3 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:52 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 2,362 | $11.23 Strike: $11.23 | $26,525.26 |
DisclosureSEC source: 0001070081-20-000003 · wf-form4_157834756203774.xml · derivative · entry 5 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,938 Underlying: Common Stock · 2,362 shares Expires 2027-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. F4 · derivative.exercise_date: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:52 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 2,362 | $47.89 | $113,111.46 |
DisclosureSEC source: 0001070081-20-000003 · wf-form4_157834756203774.xml · nonDerivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,584 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.55 to $48.46 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:52 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 2,362 | $11.23 | $26,525.26 |
DisclosureSEC source: 0001070081-20-000003 · wf-form4_157834756203774.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. F2 · balance_after: Includes 371 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2019 and 276 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2019. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 01:40 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 9,297 | $18.01 Strike: $18.01 | $167,438.97 |
DisclosureSEC source: 0001070081-19-000042 · wf-form4_156211801686164.xml · derivative · entry 18 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 9,297 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 9, 2018. F5 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 01:40 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 641 | $30.86 Strike: $30.86 | $19,781.26 |
DisclosureSEC source: 0001070081-19-000042 · wf-form4_156211801686164.xml · derivative · entry 17 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,310 Underlying: Common Stock · 641 shares Expires 2026-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 9, 2018. F4 · derivative.exercise_date: This option was granted on January 4, 2016 and vests over four years, with 25% of the shares underlying the option vested on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 01:40 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 3,133 | $0.00 Strike: $27.05 | $0.00 |
DisclosureSEC source: 0001070081-19-000042 · wf-form4_156211801686164.xml · derivative · entry 16 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,133 shares Expires 2024-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 9, 2018. F3 · derivative.exercise_date: Currently exercisable. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 01:40 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 9,297 | $45.15 | $419,750.25 |
DisclosureSEC source: 0001070081-19-000042 · wf-form4_156211801686164.xml · nonDerivative · entry 12 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,937 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 9, 2018. F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $45.00 to $45.15 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 01:40 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 9,297 | $18.01 | $167,438.97 |
DisclosureSEC source: 0001070081-19-000042 · wf-form4_156211801686164.xml · nonDerivative · entry 11 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 9, 2018. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 01:40 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 641 | $45.15 | $28,940.51 |
DisclosureSEC source: 0001070081-19-000042 · wf-form4_156211801686164.xml · nonDerivative · entry 10 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,937 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 9, 2018. F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $45.00 to $45.15 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 01:40 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 641 | $30.86 | $19,781.26 |
DisclosureSEC source: 0001070081-19-000042 · wf-form4_156211801686164.xml · nonDerivative · entry 9 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 9, 2018. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 01:40 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 3,133 | $45.15 | $141,451.82 |
DisclosureSEC source: 0001070081-19-000042 · wf-form4_156211801686164.xml · nonDerivative · entry 8 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,937 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 9, 2018. F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $45.00 to $45.15 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 01:40 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 3,133 | $27.05 | $84,747.65 |
DisclosureSEC source: 0001070081-19-000042 · wf-form4_156211801686164.xml · nonDerivative · entry 7 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 9, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.